What does connect Biopharma Holdings Ltd do?

The Company, through its subsidiaries, focuses on developing therapies for the treatment of T cell-driven inflammatory diseases. Connect Biopharma Holdings serves customers worldwide. Stock analysis for Connect Biopharma Holdings Ltd (CNTB:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

What is the target price for connect Biopharma (CNTB)?

3 brokerages have issued 12-month target prices for Connect Biopharma's shares. Their CNTB share price forecasts range from $7.00 to $7.00. On average, they expect the company's stock price to reach $7.00 in the next year. This suggests a possible upside of 629.2% from the stock's current price.

How many research reports have been made about connect Biopharma?

Connect Biopharma has only been the subject of 1 research reports in the past 90 days. Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation.

What is the upside for connect Biopharma?

According to analysts' consensus price target of $7.00, Connect Biopharma has a forecasted upside of 629.2% from its current price of $0.96. Connect Biopharma has only been the subject of 1 research reports in the past 90 days.